TTNP - Kapitalisasi marang volume dodolan Titan Pharmaceuticals Inc.

Tandha merek Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals is establishing strategic partnerships to integrate ProNeura systems into addiction therapy. The company's capitalization is based on the implementation of long-acting implants. The price-to-sales ratio dynamics reflect current market phases, where the parameter value equals 43.80. The firm's environmental policy remains formal, limited to standard waste disposal within its laboratory complexes.

Rasio rega marang pendapatan: Titan Pharma (TTNP) kanggo 04.07.2022 - 16.08.2024

Rincian metrik lan analitis perusahaan Titan Pharmaceuticals (TTNP)

- rega lan prakiraan konsensus rega:
Bagan bursa titanpharm.com|TTNP - Target konsensus
- statistik kapitalisasi pasar:
Nilai pasar Titan Pharma|TTNP - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham Titan Pharmaceuticals|TTNP - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku titanpharm.com|TTNP - Gunggung Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Titan Pharmaceuticals|TTNP - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas titanpharm.com|TTNP - Gunggung utang perusahaan|Rasio utang marang aset resik Titan Pharma|TTNP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Titan Pharmaceuticals|Rasio jangkoan perantara titanpharm.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
TTNP - Bathi resik perusahaan|Bathi mangsa ngarep Titan Pharmaceuticals|TTNP - Pangali P/E|Pangali Forward P/E titanpharm.com|TTNP - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Titan Pharma|TTNP - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Titan Pharmaceuticals|TTNP - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan titanpharm.com|TTNP - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Titan Pharmaceuticals
- data total pendapatan lan volume dodolan:
TTNP - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan titanpharm.com|TTNP - Multiplikator P/S|Multiplikator forward rega marang pendapatan Titan Pharma
Analisis umum perusahaan:Titan Pharmaceuticals Inc., TTNP
Produk dadi Titan Pharmaceuticals

Titan Pharmaceuticals maintains a high business valuation driven by its technological advantage in developing ProNeura implants for long-term drug release. GURU.Markets analysts utilize the enterprise value-to-revenue ratio to determine the premium paid for every dollar of sales and identify the risk of overpayment relative to industry norms, monitoring the stability of this balance on the chart.

Perusahaan pesaing

Koefisien rega marang pendapatan indivior.com|Collegium Pharmaceutical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan CRON (Cronos Group Inc)|Tweed - Multiplikator P/S|HITI - Multiplikator P/S|auroramj.com (ACB) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ACHV|Kapitalisasi marang pendapatan SKYE|ANEB: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan InterCure Ltd. (INCR)|NTRB: Rasio rega marang dodolan|Multiplikator P/S NSRX (Nasus Pharma)|Rasio kapitalisasi pasar marang pendapatan IGC|MIRA Pharma - Multiplikator P/S|FLGC - Multiplikator P/S|imcannabis.com (IMCC) - Rasio rega marang pendapatan|Adial Pharmaceuticals, Inc. - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Artelo Biosciences Inc.|Kapitalisasi marang pendapatan Ensysce (ENSC)|Multiplikator P/S GNLN|Multiplikator P/S InMed Pharmaceuticals Inc (INM)|Multiplikator P/S AKAN (Akanda Corporation)|ENVB - Kapitalisasi marang pendapatan|Bright Green Corp - Multiplikator P/S|Rega marang dodolan Hempacco Co Inc.